| Name | Title | Contact Details |
|---|
Metabolex, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Metabolex, Inc. is based in Hayward, CA. You can find more information on Metabolex, Inc. at www.metabolex.com
Memorial Hospital is a proud part of University of Colorado Health, recognized as a national leader in quality and research. At the local level, Memorial provides a comprehensive list of inpatient and outpatient services at two hospitals and multiple outpatient locations. Memorial provides state-of-the-art, compassionate care in fields such as cardiology, neurology and oncology.
Shodair Children's Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Helena, MT. To find more information about Shodair Children's Hospital, please visit www.shodair.org
ShapeUp is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Providence, RI. To find more information about ShapeUp, please visit www.shapeup.com
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.